Journal of Molecular Medicine-Jmm

Papers
(The H4-Index of Journal of Molecular Medicine-Jmm is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The molecular and cellular landscape of hypertrophic cardiomyopathy phenotypes: transition from obstructive to end-stage heart failure77
Kat7 accelerates osteoarthritis disease progression through the TLR4/NF-κB signaling pathway68
Soluble LDL-receptor is induced by TNF-α and inhibits hepatocytic clearance of LDL-cholesterol67
Metabolomics reveals that chronic restraint stress alleviates carbon tetrachloride-induced hepatic fibrosis through the INSR/PI3K/AKT/AMPK pathway64
Eucalyptol induces osteoblast differentiation through ERK phosphorylation in vitro and in vivo62
Retraction Note: Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells60
Glycosylation is a key in SARS-CoV-2 infection58
Mitochondrial transplantation as a possible therapeutic option for sarcopenia55
The role of CD146 in renal disease: from experimental nephropathy to clinics50
Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma48
Sex hormone binding globulin (SHBG) modulates mitochondrial dynamics in PPARγ-depleted equine adipose derived stromal cells44
PCDH11X mutation as a potential biomarker for immune checkpoint therapies in lung adenocarcinoma37
Protective role of M3 muscarinic acetylcholine receptor in indomethacin-induced small intestinal injury36
Removal of GIT lesions and the role of impedance of the injection solution—an innovative approach to known methods35
Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy34
The mutual interplay of redox signaling and connexins34
A novel ceRNA regulatory network involving the long noncoding NEAT1, miRNA-466f-3p and its mRNA target in osteoblast autophagy and osteoporosis33
Nrf2 as a potential target for Parkinson’s disease therapy33
I536T variant of RBM20 affects splicing of cardiac structural proteins that are causative for developing dilated cardiomyopathy33
X-linked genes exhibit skewed expression in Sjogren’s disease (SjD): a further step toward understanding the female predominance of autoimmune disease30
Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder29
Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy29
IGFBP2 function as a novel biomarker for active lupus nephritis29
Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice28
ABCB1 in dermatology: roles in skin diseases and their treatment27
Histone modification in podocyte injury of diabetic nephropathy27
WWOX and metabolic regulation in normal and pathological conditions26
Unleashing the power of NK cells in anticancer immunotherapy26
The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration26
Correction to: The recurrent missense mutation p.(Arg367Trp) in YARS1 causes a distinct neurodevelopmental phenotype26
0.06138801574707